Dokumentenart: | Artikel | ||||
---|---|---|---|---|---|
Titel eines Journals oder einer Zeitschrift: | European Urology | ||||
Verlag: | ELSEVIER SCIENCE BV | ||||
Ort der Veröffentlichung: | AMSTERDAM | ||||
Band: | 63 | ||||
Nummer des Zeitschriftenheftes oder des Kapitels: | 4 | ||||
Seitenbereich: | S. 739-744 | ||||
Datum: | 2013 | ||||
Institutionen: | Medizin > Lehrstuhl für Pathologie Medizin > Lehrstuhl für Urologie | ||||
Identifikationsnummer: |
| ||||
Stichwörter / Keywords: | BLADDER-CANCER; NEOADJUVANT CHEMOTHERAPY; EXTRACAPSULAR EXTENSION; METASTASES; DISSECTION; SURVIVAL; LEVEL; Bladder cancer; Lymphatic metastasis; Cystectomy; Perinodal lymphovascular invasion; Extranodal extension | ||||
Dewey-Dezimal-Klassifikation: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin | ||||
Status: | Veröffentlicht | ||||
Begutachtet: | Ja, diese Version wurde begutachtet | ||||
An der Universität Regensburg entstanden: | Ja | ||||
Dokumenten-ID: | 62722 |
Zusammenfassung
Background: Metastasis of urothelial carcinoma of the bladder (UCB) into regional lymph nodes (LNs) is a key prognosticator for cancer-specific survival (CSS) after radical cystectomy (RC). Perinodal lymphovascular invasion (pnLVI) has not yet been defined. Objective: To assess the prognostic value of histopathologic prognostic factors, especially pnLVI, on survival. Design, setting, and ...
Zusammenfassung
Background: Metastasis of urothelial carcinoma of the bladder (UCB) into regional lymph nodes (LNs) is a key prognosticator for cancer-specific survival (CSS) after radical cystectomy (RC). Perinodal lymphovascular invasion (pnLVI) has not yet been defined. Objective: To assess the prognostic value of histopathologic prognostic factors, especially pnLVI, on survival. Design, setting, and participants: A total of 598 patients were included in a prospective multicentre study after RC for UCB without distant metastasis and neoadjuvant and/or adjuvant chemotherapy. En bloc resection and histopathologic evaluation of regional LNs were performed based on a prospective protocol. The final study group comprised 158 patients with positive LNs (26.4%). Intervention: Histopathologic analysis was performed based on prospectively defined morphologic criteria of LN metastases. Outcome measurements and statistical analysis: Multivariable Cox proportional hazard regression models determined prognostic impact of clinical and histopathologic variables (age, gender, tumour stage, surgical margin status, pN, diameter of LN metastasis, LN density [LND], extranodal extension [ENE], pnLVI) on CSS. The median follow-up was 20 mo (interquartile range: 11-38). Results and limitations: Thirty-one percent of patients were staged pN1, and 69% were staged pN2/3. ENE and pnLVI was present in 52% and 39%, respectively. CSS rates after 1 yr, 3 yr, and 5 yr were 77%, 44%, and 27%, respectively. Five-year CSS rates in patients with and without pnLVI were 16% and 34% (p < 0.001), respectively. PN stage, maximum diameter of LN metastasis, LND, and ENE had no independent influence on CSS. In the multivariable Cox model, the only parameters that were significant for CSS were pnLVI (hazard ratio: 2.47; p = 0.003) and pT stage. However, pnLVI demonstrated only a minimal gain in predictive accuracy (0.1%; p = 0.856), and the incremental accuracy of prediction is of uncertain clinical value. Conclusions: We present the first explorative study on the prognostic impact of pnLVI. In contrast to other parameters that show the extent of LN metastasis, pnLVI is an independent prognosticator for CSS. (C) 2012 European Association of Urology. Published by Elsevier B. V. All rights reserved.
Metadaten zuletzt geändert: 19 Dez 2024 08:41